Let's Talk VWD

Von Willebrand Disease commonly known as VWD is the most inherited bleeding disorder that effects up to 1% of the general population including both men and women. As members of the bleeding disorders community, we understand the process of diagnosis and treatment of bleeding disorders and how it can be instrumental in making sure affected individuals receive the care they need.

NHF’s Medical and Scientific Advisory Council has released new guidelines for both physicians and the community that recommend the best methods for the treatment of VWD. To view these guidelines, feel free to follow one of the few links below:

1) https://www.hemophilia.org/healthcare-professionals/guidelines-on-care/masac-documents/masac-document-266-masac-recommendations-regarding-the-treatment-of-von-willebrand-disease

2) https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/von-willebrand-disease

If you would like to receive more information, there will be a Wednesday Webinar hosted by NHF this upcoming Wednesday March 24th. This webinar will address the new guidelines and what they mean for both physicians and patients. To register for this event, you may use the link provided here: https://www.hemophilia.org/events/wednesday-webinar-new-guidelines-for-vwd-patient-perspective. We hope to see you there!

Until next time!                                              -Dejah